ASXL1 and colorectal carcinoma: As reported early, ASXL1, circASXL1 patient, has been reported to be negatively correlated with lymph node metastasis of CRC [38], and to inhibit CRC cell proliferation through acting as a target of miR-3187-3p [39], which was opposite to the function of circASXL1.